RT Book, Section
A1 Rogers, Kelly C.
A1 Spinler, Sarah A.
A2 Chisholm-Burns, Marie A.
A2 Schwinghammer, Terry L.
A2 Malone, Patrick M.
A2 Kolesar, Jill M.
A2 Bookstaver, P. Brandon
A2 Lee, Kelly C.
SR Print(0)
ID 1187007391
T1 Acute Coronary Syndromes
T2 Pharmacotherapy Principles & Practice, 6e
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781260460278
LK apn.mhmedical.com/content.aspx?aid=1187007391
RD 2024/04/23
AB LEARNING  OBJECTIVESUpon  completion  of  the  chapter,  the  reader  will  be  able  to:Define  the  role  of  atherosclerotic  plaque,  platelets,  and  the  coagulation  system  in  an  acute  coronary  syndrome  (ACS).List  key  electrocardiographic  (ECG),  biomarker,  and  clinical  features  identifying  a  patient  with  non–ST-segment  elevation  (NSTE)-ACS  and  ST-segment  elevation  myocardial  infarction  (STEMI).Devise  an  initial,  early  pharmacotherapy  treatment  and  monitoring  plan  for  a  patient  presenting  with  either  NSTE-ACS  or  STEMI  given  patient-specific  data.Devise  an  antithrombotic  pharmacotherapy  treatment  and  monitoring  plan  for  a  patient  with  NSTE-ACS  or  STEMI  undergoing  percutaneous  coronary  intervention  (PCI)  given  patient-specific  data.Devise  an  antithrombotic  pharmacotherapy  treatment  and  monitoring  plan  for  a  patient  with  NSTE-ACS  or  STEMI  not  undergoing  PCI  given  patient-specific  data.Develop  a  pharmacotherapy  and  risk  factor  modification  treatment  plan  for  secondary  prevention  of  coronary  heart  disease  (CHD)  events  in  a  patient  following  NSTE-ACS  or  STEMI.